US Broker Ratings

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 69% Potential Upside Beckons Investors

Beam Therapeutics Inc. (NASDAQ: BEAM), a rising star in the biotechnology sector, presents a captivating opportunity for investors keen on genetic medicine. With a market capitalization of $2.75 billion, Beam..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 53.57% Upside in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the biotechnology sector, has caught the attention of investors with a noteworthy potential upside of 53.57%. As a clinical-stage biotechnology company,..

Dyne Therapeutics, Inc. (DYN): Investor Outlook with a Promising 65.82% Upside Potential

Investors with an eye on the biotechnology sector may find Dyne Therapeutics, Inc. (NASDAQ: DYN) an intriguing proposition. With a current market capitalization of $3.17 billion, Dyne Therapeutics, a clinical-stage..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector specializing in drug manufacturing for both specialty and generic markets, presents a complex picture for potential investors. Operating within China..

Kestra Medical Technologies (KMTS): Investor Outlook with 51% Revenue Growth and 13.56% Potential Upside

Kestra Medical Technologies, Ltd. (KMTS), a promising player in the healthcare sector, is gaining attention from investors with its impressive revenue growth and potential upside. Specializing in wearable medical devices,..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Ratings Signal Strong Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is drawing significant attention in the healthcare sector for its innovative approach to treating serious hematologic diseases. With a market capitalization..

Arcellx, Inc. (ACLX) Stock Report: Exploring a 52.71% Potential Upside in Biotech Innovation

Arcellx, Inc. (NASDAQ: ACLX) is capturing investor attention in the biotechnology sector with its promising pipeline of immunotherapies aimed at tackling cancer and other incurable diseases. Positioned in the dynamic..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 49% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, has captured investor attention with its innovative contributions to sports medicine and severe burn care. Headquartered in Cambridge, Massachusetts,..

Neogen Corporation (NEOG) Stock Analysis: Healthcare Innovator with 35% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a key player in the Healthcare sector, operates within the Diagnostics & Research industry, focusing on ensuring food and animal safety. With a market cap of..

NewAmsterdam Pharma (NAMS) Stock Report: A Biotech Powerhouse with 30.84% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a biopharmaceutical firm based in the Netherlands, has been capturing attention in the healthcare sector with its innovative clinical trials aimed at combating metabolic..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring the 18.80% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Guardian Pharmacy Services, Inc. (GRDN) an intriguing prospect. With its focus on providing technology-enabled services to long-term healthcare facilities (LTCFs) in..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Robotics Pioneer with 46.64% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving out a niche in the healthcare sector, specifically within the medical devices industry. With a strategic focus on developing transformative surgical robotics solutions,..

Indivior PLC (INDV) Stock Analysis: A Look at the 3.43% Potential Upside and Strong Buy Ratings

Indivior PLC (INDV) stands out in the healthcare sector, focusing on specialty and generic drug manufacturing. Its core mission revolves around developing and delivering buprenorphine-based prescription drugs, primarily targeting opioid..

Artivion, Inc. (AORT) Stock Analysis: Unveiling a 17% Potential Upside in the Medical Devices Sector

For investors with a keen eye on the healthcare sector, Artivion, Inc. (AORT) presents an intriguing opportunity. As a key player in the medical devices industry, Artivion has a market..

Immunocore Holdings (IMCR) Stock Analysis: A 67.65% Potential Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology landscape with a compelling growth narrative that promises significant upside potential for investors. With a market capitalization of $1.93 billion,..

GRAIL, Inc. (GRAL) Stock Analysis: Analyzing the 5.21% Upside Potential in Healthcare Diagnostics

GRAIL, Inc. (NASDAQ: GRAL), a leader in the diagnostics and research sector of the healthcare industry, has captured the attention of investors with its innovative approach to multi-cancer early detection...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring Growth Potential Amidst a $9.48 Billion Market Cap

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotechnology sector with its robust development pipeline and strategic partnerships. As a U.S.-based company focused on innovative treatments for intractable diseases,..

Progyny, Inc. (PGNY) Investor Outlook: Strong Buy Ratings and Double-Digit Upside Potential

Progyny, Inc. (NASDAQ: PGNY) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $2.13 billion, this U.S.-based company has carved..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Navigating a Challenging Landscape with a 16% Upside Potential

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, has been making waves in the investment community. With a..

Haemonetics Corporation (HAE) Stock Analysis: Healthcare Innovator with 3.24% Upside Potential

Haemonetics Corporation (NYSE: HAE) is a notable player in the healthcare sector, particularly within the medical devices industry. Based in Boston, Massachusetts, Haemonetics specializes in providing sophisticated medical technology solutions..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds